Secondary graft failure after autologous stem cell transplantation for primary central nervous system lymphoma responds to ciclosporin and eltrombopag.

Primary central nervous system lymphoma: Evolving treatment strategies to achieve improved long-term disease control.

Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: CT vs MRI.

Cystatin C regulates cell division in primary central nervous system lymphoma.

Treatment initiation by positive liquid biopsy alone in primary central nervous system lymphoma: A retrospective analysis of a multi-institutional study.

The Regulation of Vasomotor and Cardiorespiratory Pulsations Is Disrupted in Primary Central Nervous System Lymphoma: A Case-Control fMRI Study.

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis.

Effective high-dose methotrexate toxicity reversal using fixed-dose glucarpidase in obese patients: a case series.

HIV-associated lymphoproliferative disorders: Single-center experience.

Improving MRI-based differentiation of brain metastasis, glioblastoma, and primary CNS lymphoma using deep learning.

Movement disorders due to primary central nervous system lymphoma: An illustrative case and systematic literature review.

Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective study.

An Update on Treatments for Recurrent Primary Central Nervous System Lymphoma.

Primary Dural Diffuse Large B-Cell Lymphoma: A Report of a Rare Case and Review of the Literature.

Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma.

KPT-8602 combined with IFN-γ released ZBP1-PANoptosome to inhibit the progression of primary central nervous system lymphoma.

Primary Central Nervous System Lymphoma With Testicular and Prostatic Involvement: A Case Report.

Brain Lesions Associated with Human Immunodeficiency Virus Infection in the Antiretroviral Therapy Era: A Single-center Experience in Japan.

Advances in liquid diagnostics for primary central nervous system lymphoma: a narrative review.

A case report: primary central nervous system lymphoma misdiagnosed as neuromyelitis optica.

[Coexistence of primary central nervous system lymphoma and cerebral toxoplasmosis in a patient with advanced HIV infection and negative serology].

Time matters: The prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma-a single-center, retrospective real-world study.

Exosomal ANGPTL2 in cerebrospinal fluid as a novel prognostic biomarker for primary central nervous system lymphoma.

Prognostic Assessment of Surgical Strategies and Extent of Resection in Methotrexate-Based Treatment for Primary Central Nervous System Lymphoma: A Propensity-Matched Analysis.

Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma.

Clinical Characteristics and Prognosis of Primary Central Nervous System Lymphoma: A Retrospective Analysis.

Strategies for Managing Toxicities With High-Dose Methotrexate in Haematological Malignancies: Lessons From Clinical Cases.

Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial.

A 62-Year-Old-Man With Severe Daytime Sleepiness After Primary Central Nervous System Lymphoma.

Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma.

Incidence and Management of Tirabrutinib-associated Cutaneous Adverse Events: A Case Series.

Composite lymphoma comprising adult T-cell leukemia/lymphoma and Epstein-Barr virus-positive primary central nervous system lymphoma.

Zanubrutinib, lenalidomide, rituximab, temozolomide ± methotrexate as first-line treatment for primary central nervous system lymphoma: A prospective, open-label, multicentre clinical trial.

Diagnostic utility of cerebrospinal fluid IgG index, 24-hour IgG synthesis rate, and immunophenotyping in primary central nervous system large B-cell lymphoma: A case report.

Differentiation of high-grade glioma and primary central nervous system lymphoma based on imaging heterogeneity scoring system.

Development and validation of multiple machine learning algorithms for differentiating primary central nervous system lymphoma from adult-type diffuse glioma: an interpretable and multicenter study.

Primary dural lymphoma of the chronic lymphocytic lymphoma/small lymphocytic lymphoma-mimicking meningioma: illustrative case.

Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL).

Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy.

Early Diagnostic Value of Contrast-Enhanced MRI in Distinguishing Toxoplasmic Encephalitis from CNS Lymphoma: A Case Report of AIDS with Seronegative Toxoplasmosis.

Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma: Results From the International Radiosurgery Research Foundation.

Behavioral Changes as the Initial Presentation of Primary Central Nervous System Lymphoma: A Case Report.

It Is Not Always Metastasis: A Case Report of a Primary Nervous System Anaplastic Large Cell Lymphoma and the Relevance of Brain Biopsy.

Primary central nervous system lymphoma in children: Insights from the three-year experience at the largest public-sector pediatric oncology center in Pakistan.

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Multifocal anaplastic astrocytoma mimicking primary central nervous system lymphoma: A case report.

A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.

LINNDA: Lymphoma identification through neural network detection aid.

New biomarkers for the diagnosis of primary central nervous system lymphoma in CSF: A multicenter retrospective cohort study.

Evaluation of programmed cell death ligand-1 expression in primary central nervous system lymphoma using whole-tumor histogram analysis of multiparametric MRI: implications for immunotherapy selection.

Primary Central Nervous System Lymphoma: A Case Report of the Neurological Great Mimicker.

A Durable Remission Following Pseudo-Progression in Tirabrutinib Treatment for Relapsed Primary Central Nervous System Lymphoma: A Case Study.

Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphoma.

Successful combined treatment for primary central nervous system lymphoma with massive hemorrhage: Illustrative case.

[Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma].

Real-world survival, cognitive, and quality of life outcomes of methotrexate/ifosfamide plus whole brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

Intraocular Lymphoma: A Review.

A retrospective analysis of autologous stem cell transplantation conditioning with reduced-dose busulfan/thiotepa for patients with central nervous system lymphomas at a single institution.

Tirabrutinib rechallenge achieved complete response for recurrent primary central nervous system lymphoma: illustrative case.

Successful treatment of primary intramedullary spinal cord lymphoma based on the molecular diagnosis of a MYD88 mutation in the cerebrospinal fluid: a case report.

Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma.

Effectiveness and safety of orelabrutinib combined with rituximab, temozolomide, methotrexate, and cytarabine in intensive chemotherapy-unfit patients with PCNSL in China.

Prebiopsy Steroids and Diagnostic Yield in Patients With Diffuse Large B-Cell Lymphoma.

Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma.

Multiple primary central nervous system lymphoma in the ventricular system and interpeduncular cistern: A case report.

A Case Report of HIV-Associated Pituitary Lymphoma and Review of the Literature.

Development and validation of a convolutional neural network for automatic differentiation of primary central nervous system lymphoma and glioblastoma.

A Novel Prognostic Model for Primary CNS Lymphoma Incorporating Clinico-Laboratory Parameters.

Elevated polyglutamylation and tau phosphorylation levels are associated with cognitive impairment at diagnosis in patients with primary central nervous system lymphoma.

[Primary lymphoma of the central nervous system].

Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis.

Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric study.

Efficacy and Limitations of Flow Cytometry for the Rapid Diagnosis of Primary Central Nervous System Lymphoma.

Genomic landscape and molecular subtypes of primary central nervous system lymphoma.

Diagnostic Potential of Cerebrospinal Fluid Biomarkers in Diagnosis of Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis.

Electron Density and Effective Atomic Number as Quantitative Biomarkers for Differentiating Malignant Brain Tumors: An Exploratory Study with Machine Learning.

Outcomes for Primary Central Nervous System Lymphoma from a Single Institution.

Primary Central Nervous System Lymphoma Associated With Immune Deficiency and Dysregulation: Challenges in Treatment and Management.

A Case of Primary Central Nervous System Lymphoma Mimicking a Demyelinating Disorder: From Steroids to Stem Cell Transplant.

Primary central nervous system lymphoma mimicking an otitis media complication: an unusual presentation with sigmoid sinus thrombosis.

Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case report.

Orelabrutinib plus reduced-dose whole brain radiotherapy in elderly primary central nervous system lymphoma: a case report.

[The Efficacy and Safety of Modified Thiotepa-Based Conditioning Followed by Autologous Stem Cell Transplantation in Primary CNS Lymphomas].

Hypothalamic-Pituitary Axis Involvement in Primary Central Nervous System Lymphoma: A Systematic Review.

Chemotherapy-Free Salvage Therapy with Rituximab, Lenalidomide, and Poseltinib in Relapsed or Refractory Primary Central Nervous System Lymphoma: A Multi-Center, Phase II Study.

Primary Dural Diffuse Large B-Cell Lymphoma: A Case Report.

Role of rituximab in treatment of patients with primary central nervous system lymphoma: An updated systematic review and meta-analysis.

u-LINNDA: A protocol for user-optimized lymphoma identification through neural network detection aid.

Mass cytometric analysis of circulating immune landscape in primary central nervous system lymphoma.

Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.

Interpretable radiomics-based machine learning model for differentiating glioblastoma from primary central nervous system lymphoma using contrast-enhanced T1-weighted imaging.

Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.

Evaluation of Prognostic Factors in Primary Central Nervous System Lymphomas: A Single-Center Study.

Preoperative multiparameter MRI-based prediction of Ki-67 expression in primary central nervous system lymphoma.

Study of plasma exosomal miRNAs as novel biomarkers for differentiating primary central nervous system lymphoma and glioblastoma.

Sellar-suprasellar pituitary lymphoma mimicking pituitary adenoma: a case report with literature review.

Clinical utility of repeat brain biopsy in recurrent or refractory primary CNS lymphoma - a diagnostic dilemma.

Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results.

Specific Marker Gene Analysis for Primary Central Nervous System Lymphoma Based on Methylation Difference and Development of Detection Primers.

[Clinical characteristics and prognosis of 52 patients with primary central nervous system lymphoma].

Targeting PD-L1 for PCNS-DLBCL: from molecular effects to clinical translation.

Clinical characteristics and prognosis of ventricular primary central nervous system lymphoma: a case series and literature review.

Population pharmacokinetics of high-dose methotrexate and 7-hydroxy methotrexate in Chinese adults with primary central nervous system lymphoma.

Magnetic Resonance Spectroscopy in the Evaluation of Biopsy-Indeterminate Primary Central Nervous System Lymphoma: A Case Report.

Lenalidomide-rituximab with high-dose methotrexate for treatment of patients with newly diagnosed primary cns lymphoma: a promising first-line approach.

Corticosteroid Use Before Stereotactic Brain Biopsy for Suspected Lymphoma.

Lymphomatosis cerebri presenting with rapidly progressive parkinsonism and Holmes tremor: a case report.

Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimics.

Case Report: Chronic subdural hematoma secondary to primary central nervous system lymphoma.

The role of surgical resection and stereotactic radiosurgery in PCNS-DLBCL: a retrospective analysis of clinical benefits.

Automatic Segmentation of Primary Central Nervous System Lymphoma at Clinical Routine Postcontrast T1-weighted MRI.

A Case of Relapsed/Refractory Primary Central Nervous System B-Cell Lymphoma with Renal Insufficiency Successfully Treated with Linperlisib.

The Landscape of Primary Central Nervous System Lymphoma (PCNSL): Clinicopathologic and Genomic Characteristics and Therapeutic Perspectives.

Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma.

Case Report: Effective methotrexate removal by combined hemodialysis and polymeric resin hemoadsorption.

Diagnostic Performance of CSF Interleukin-10 in Primary Central Nervous System Lymphoma: A Retrospective Study.

Co-existence of Primary Glioma and Lymphoma: An Unusual Case Report.

Management of primary central nervous system lymphoma and coexisting heart failure with reduced ejection fraction: a narrative review.

Radiation Retinopathy After Whole-Brain Radiotherapy in a Patient With Pineal Gland Tumor.

NMDAR-Antibody Encephalitis Diagnosed With Primary Central Nervous System Lymphoma: A Case Series.

Bloodstream Infection Caused by Mycobacterium neoaurum in a Primary Central Nervous System Lymphoma Patient with Toxic Epidermal Necrolysis.

Multiparametric MRI for differential diagnosis of primary central nervous system lymphoma and atypical glioblastoma: an analysis incorporating DWI, DCE-MRI, and contrast agent preload DSC-PWI.

The Role of Percentage Signal Recovery (PSR) in MRI Perfusion for the Diagnosis of Primary Central Nervous System Lymphoma.

Primary Central Nervous System B-Cell Lymphoma Presenting with Fluctuating Basal Ganglia and Cortical Lesions.

Tumor Habitats Based on Multiparametric MRI Distinguish Atypical Glioblastoma From Primary Central Nervous System Lymphoma: Imaging-Pathologic Correlation.

Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma.

Primary central nervous system lymphomas in three "blue books" and correlation of recently defined primary large B-cell lymphoma of immune-privileged sites: Single-center experience.

Clinicopathological Significance of Tumor-Infiltrating T Lymphocytes and Macrophages in Primary Large B-Cell Lymphoma of Immune-Privileged Sites.

Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives.

Secondary Versus Recurrent Central Nervous System Lymphoma: Evaluating the Similarities and Differences in a Single-Institution Cohort.

Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma.

Clinical characteristics and prognosis of primary central nervous system lymphoma in China: a single-center retrospective analysis of 325 patients.

Histogram analysis based on DTI and NODDI for differentiating atypical high-grade glioma from primary central nervous system lymphoma.

New treatment strategies for primary central nervous system lymphoma.

Molecular Characterization and Therapeutic Implications of MYD88 and CDKN2A in Primary CNS Lymphoma.

Prognosticating salvage stereotactic radiosurgery outcomes in relapsed primary central nervous system lymphoma: A machine learning-driven decision tree analysis.

Exploration of the Optimal Treatment Modality for Vitreoretinal Lymphoma: A PRISMA Compliant Meta-Analysis and Systematic Review.

The Diagnostic Yield of Cerebrospinal Fluid Analysis for the Diagnosis of Primary Central Nervous System Lymphoma: A Systematic Review.

A nomogram for predicting the diagnosis of central malignant tumors based on preoperative clinical characteristics and laboratory indicators: a diagnostic study.

Comparative analysis of the tumor microenvironment in primary CNS and testicular large B-cell lymphomas using digital image analysis and its implications for immunotherapy.

PDL1 Gene Gain Predicts an Unfavorable Prognosis in HIV-Positive Primary Central Nervous System Lymphoma.

Case report: diagnostic challenges of primary central nervous system anaplastic large cell lymphoma, ALK-positive.

Programmed death inhibitors in CNS B-cell lymphoma: A literature review.

Real-World Efficacy and Safety of the Combination of Rituximab, Lenalidomide, and Ibrutinib in Patients with Relapsed and/or Refractory Non-Hodgkin Lymphoma.

Vasomotor fluctuations are increased in primary central nervous system lymphoma: a case-control study with fast functional MRI.

Diagnostic Odyssey: Primary CNS Lymphoma (Lymphoma Cerebri) Presenting as Rapidly Progressive Dementia.

Circulating tumor DNA in B cell lymphomas.

Clinical Characteristics, Prognostic Risk Factors, and Primary Treatment for Elderly Patients with Primary Central Nervous System Lymphoma: A Seer Database-Based Research.

Dexamethasone-associated regression of glioblastoma.

Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma.

Clinical Predictors and Recurrence Characteristics Following Radiotherapy for Primary Central Nervous System Lymphoma: A Retrospective Cohort Study.

Whole-Eye Radiation for the Local Control of Choroidal Lymphoma in Primary Central Nervous System Lymphoma: A 14-Year Case Study.

Ultra-sensitive detection of microRNA in intraocular fluid using optical fiber sensing technology for central nervous system lymphoma diagnosis.

Meeting Report From the 2024 Symposium on IRAK4 in Cancer: Highlights and Clinical Updates.

Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma.

Clinically probable paraneoplastic vasculitic peripheral neuropathy in primary central nervous system lymphoma: a case report.

Molecular diagnosis of vitreoretinal lymphoma.

Immune Checkpoint Molecule Expression, 9p24.1 Gene Alterations, and Tumor Microenvironment of Primary Central Nervous System Lymphomas and Their Clinical Relevance.

Plasmablast-like lymphoma cells as a distinct subpopulation confer multidrug resistance in PCNSL.

Primary central nervous system lymphoma: Predictors of response to induction therapy and patterns of progression.

Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Diffusion-weighted imaging and susceptibility-weighted imaging in differentiating ring-enhancing primary central nervous system lymphoma from infections.

Primary central nervous system lymphoma: A 7 years single-center experience.

A Case of Primary Central Nervous System T-cell Lymphoma of the Spinal Cord Detected by 18 F-FDG PET/CT.

Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO).

Large B-cell Lymphoma With Interferon Regulatory Factor 4 Rearrangement Presenting as a Primary Central Nervous System Lymphoma in the Brain.

Identifying risk factors for methotrexate-induced acute kidney injury despite full prevention in patients with primary central nervous system lymphoma.

Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study.

Radiomics-Based Differentiation of Primary Central Nervous System Lymphoma and Solitary Brain Metastasis Using Contrast-Enhanced T1-Weighted Imaging: A Retrospective Machine Learning Study.

Population pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma.

Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system lymphoma.

Novel Therapies in Primary Central Nervous System Lymphoma.

The activation of the NF-κB p65/PD-L1 signaling pathway in AIDS-related PCNSL is related to TNF-α and IFN-γ but not to MYD88 and CD79B mutations.

Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System-Outcomes in Finland: A Nationwide Population-Based Study.

Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside.

Orelabrutinib combined with rituximab and high-dose methotrexate as induction therapy in newly diagnosed primary central nervous system lymphoma.

Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma.

OCT4 and Nestin Expression in the Microenvironment of Primary Central Nervous System Lymphomas.

Complex Differential Diagnosis Between Cerebral Toxoplasmosis and Primary CNS Lymphoma in Immunocompromised Patients: The Value of Brain Biopsy.

Diagnostic Challenges in an Elderly Patient With Cognitive Decline and an Incidental Brain Mass.

Accumulation of N-Isopropyl-p(123I)iodoamphetamine on Single-Photon Emission Computed Tomography Between Immunosuppressed and Non-immunosuppressed Patients With Primary Central Nervous System Lymphoma.

Efficacy and safety of the R2-MTX regimen in primary central nervous system lymphoma (PCNSL): a single-center retrospective analysis.

Establishment and evaluation of an automatic multi?sequence MRI segmentation model of primary central nervous system lymphoma based on the nnU?Net deep learning network method.

Metabolic pathway alterations in cerebrospinal fluid as diagnostic biomarkers for primary central nervous system lymphoma.

Mild Metabolism Increase on Posttreatment 18 F-FDG PET may Indicate Recurrence of Primary CNS Lymphoma.

The "purfling sign": a new imaging marker for the diagnosis of primary CNS lymphoma.

Role of Radiotherapy in PCNSL within the Current Therapeutic Landscape: a Comprehensive Review.

Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis.

Primary vitreoretinal lymphoma: diagnosis, treatment, and prognosis-a review of current knowledge and future directions.

Prediction of early recurrence in primary central nervous system lymphoma based on multimodal MRI-based radiomics: A preliminary study.

A Natural Course From Primary Intraocular Lymphoma to Brain Lymphoma in Four Years According to Patient's Choice.

Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma.

Safety and efficacy of programmed cell death-1 inhibitors in relapsed immune-privileged site lymphoma: A systematic review and meta-analysis.

Whole brain radiotherapy combined with CART-cell therapy for relapsed/refractory central nervous system B-cell lymphoma.

PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

Machine Learning-Enhanced Cerebrospinal Fluid N-Glycome for the Diagnosis and Prognosis of Primary Central Nervous System Lymphoma.